`Trials@uspto.gov
`Tel: 571-272-7822
`Entered: July 13, 2018
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APOTEX INC. and APOTEX CORP.,
`Petitioners,
`v.
`ABRAXIS BIOSCIENCE, LLC,
`Patent Owner.
`
`Case IPR2018-00151 (Patent 8,138,229 B2)
`Case IPR2018-00152 (Patent 7,820,788 B2)
`Case IPR2018-00153 (Patent 7,923,536 B2)
`
`Before JEFFREY N. FREDMAN, RAMA G. ELLURU, and
`SUSAN L. C. MITCHELL, Administrative Patent Judges.
`
`FREDMAN, Administrative Patent Judge.
`
`JUDGMENT
`Termination of the Proceeding
`35 U.S.C. § 317(a); 37 C.F.R. § 42.72
`
`On January 29, 2018, pursuant to 35 U.S.C. § 317(a), the parties
`filed a Joint Motion to terminate each of the above-referenced
`proceedings. IPR2018-00151, Paper 11; IPR2018-00152, Paper 12;
`
`
`
`IPRs 2018-00151, 2018-00152, 2018-00153
`Patents 7,820,788 B2, 7,923,536 B2, 8,138,229 B2
`
`
`IPR2018-00153, Paper 111. Accompanying the Motion, the parties filed a
`true copy of a settlement agreement along with a Joint Request to treat the
`settlement agreement as business confidential, to be kept separate from
`the patent file under 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c).
`IPR2018-00151, Paper 12; IPR2018-00152, Paper 13; IPR2018-00153,
`Paper 12. We authorized the filing of these papers in a Board email dated
`June 15, 2018.
`We entered a Decision to Institute an inter partes review in each
`case on May 8, 2018. See IPR 2018-00151, Paper 10; IPR2018-00152,
`Paper 11; IPR2018-00153, Paper 11. Since our Decision, minimal briefing
`activity has occurred in this proceeding. The parties explain that
`termination is appropriate because (1) Petitioners and Patent Owner have
`settled their disputes and have agreed to terminate the proceeding, (2) the
`Office has not yet decided the merits of the proceeding, and (3) public
`policy favors the termination. See IPR2018-00151, Paper 11; IPR2018-
`00152, Paper 12; IPR2018-00153, Paper 11. At this juncture of the
`proceeding, the record does not contain full briefing on the trial issues and
`the Board has not entered a final decision.
`The Board generally expects that a case “will terminate after the
`filing of a settlement agreement, unless the Board has already decided the
`merits.” Office Patent Trial Practice Guide, 77 Fed. Reg. 48,756, 48,768
`(Aug. 14, 2012); see 37 C.F.R. § 42.72. Based on the facts of the case, it
`
`
`1 The motions in each proceeding are identical. Thus, we cite to the papers
`in IPR2018-00151 for convenience, unless otherwise specifically indicated.
`
`2
`
`
`
`IPRs 2018-00151, 2018-00152, 2018-00153
`Patents 7,820,788 B2, 7,923,536 B2, 8,138,229 B2
`
`
`is appropriate to enter judgment2 and terminate the proceedings without
`rendering a final written decision. See 35 U.S.C. § 317(a); 37 C.F.R. §
`42.72. We also determine that the parties have complied with the
`requirements of 37 C.F.R. § 42.74(c) to have the Settlement Agreement
`treated as business confidential information and kept separate from the
`files of the patents at issue in these proceedings. Thus, the joint motions
`to terminate the proceeding and joint requests that the settlement agreement
`be treated as business confidential information are granted.
`Accordingly, it is
`ORDERED that the joint motions in IPR2018-00151, IPR2018-
`00152, and IPR2018-00153 to terminate these proceedings are granted;
`
`FURTHER ORDERED that the proceedings in IPR2018-00151,
`IPR2018-00152, and IPR2018-00153 are terminated; and
`
`FURTHER ORDERED that the parties’ joint requests in IPR2018-
`00151, IPR2018-00152, and IPR2018-00153 that the settlement agreement
`be treated as business confidential information, to be kept separate from the
`patent file, and made available only to Federal Government agencies on
`written request, or to any person on a showing of good cause, pursuant to
`35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c) are granted.
`.
`
`
`
`
`
`
`
`2 A judgment means a final written decision by the Board, or a termination
`of a proceeding. 37 C.F.R. § 42.2.
`
`3
`
`
`
`IPRs 2018-00151, 2018-00152, 2018-00153
`Patents 7,820,788 B2, 7,923,536 B2, 8,138,229 B2
`
`PETITIONER:
`
`John Molenda
`Vishal Gupta
`Siew Chong
`STEPTOE & JOHNSON LLP
`jmolenda@steptoe.com
`schong@steptoe.com
`vgupta@steptoe.com
`
`
`PATENT OWNER:
`
`J. Patrick Elsevier
`Anthony M. Insogna
`Cary Miller
`Christopher J. Harnett
`Lisamarie LoGiudice
`JONES DAY
`jpelsevier@jonesday.com
`aminsogna@jonesday.com
`cmiller@jonesday.com
`llogiudice@jonesday.com
`charnett@jonesday.com
`
`F. Dominic Cerrito
`Andrew S. Chalson
`Daniel C. Wiesner
`Frank C. Calvosa
`QUINN EMANUEL URQUHART & SULLIVAN
`nickcerrito@quinnemanuel.com
`andrewchalson@quinnemanuel.com
`danielwiesner@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`4
`
`